An In Vitro Perspective on What Individual Antimicrobials Add to Mycobacterium avium Complex Therapies

For Mycobacterium avium complex pulmonary disease (MAC-PD), current treatment regimens yield low cure rates. To obtain an evidence-based combination therapy, we assessed the in vitro activity of six drugs, namely, clarithromycin (CLR), rifampin (RIF), ethambutol (EMB), amikacin (AMK), clofazimine (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Sonawane, Vidhisha V., Ruth, Mike M., Pennings, Lian J., Svensson, Elin M., Wertheim, Heiman F. L., Hoefsloot, Wouter, van Ingen, Jakko
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2021
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284439/
https://ncbi.nlm.nih.gov/pubmed/33972258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02730-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados